Impact of social challenges on gaining employment for veterans with posttraumatic stress disorder: an exploratory moderator analysis

Psychiatr Rehabil J. 2014 Jun;37(2):107-9. doi: 10.1037/prj0000058. Epub 2014 Apr 7.

Abstract

Objective: To explore whether psychosocial challenges impact effects of vocational rehabilitation in Veterans with Posttraumatic Stress Disorder (PTSD).

Methods: A post hoc exploratory analysis of possible moderators of treatment was conducted on outcomes from a randomized, controlled trial of Individual Placement and Support in Veterans with PTSD.

Results: When examining groups within each moderator, there was a greater IPS supportive employment benefit in gaining competitive employment for those with inadequate transportation (number needed to treat [NNT] = 1.5) and inadequate housing (NNT = 1.5) compared with the main finding of the pilot study (NNT = 2.07). Compared with the main finding of the pilot study, there was no greater advantage of IPS for those with adequate transportation (NNT = 2.4) or adequate housing (NNT = 2.4). Compared with the main finding in the pilot study, those without a family care burden had a greater benefit from IPS (NNT = 1.4) and those with family care burden had a reduced treatment effect (NNT = 3.3).

Conclusions and implications for practice: These results are exploratory and are not intended to guide clinical decision-making, but rather offer a potentially useful strategy in the design of larger trials of IPS.

Trial registration: ClinicalTrials.gov NCT00333801.

Publication types

  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Employment / psychology
  • Employment / statistics & numerical data
  • Employment, Supported / methods
  • Housing
  • Humans
  • Pilot Projects
  • Rehabilitation, Vocational / methods*
  • Stress Disorders, Post-Traumatic / psychology
  • Stress Disorders, Post-Traumatic / rehabilitation*
  • Transportation
  • Veterans / psychology*
  • Veterans / statistics & numerical data

Associated data

  • ClinicalTrials.gov/NCT00333801